Risperidone Microspheres for Injection(Ac Pharma)

注射用利培酮微球(4W)(广州帝奇医药)

Report date: 2025/08/18 17:17:37

Base Information

Drug NameRisperidone Microspheres for Injection(Ac Pharma)
Drug Alias NameRisperidona利司哌酮Risperidonum利螺环酮Risperdal Consta (利培酮) +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAc Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A